Hemodynamic MAP StabilityDELTANCT06932484
Delta Variation to Guide Hemodynamic Optimization
A study testing parameters in people with Hemodynamic MAP Stability, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS at 1 site in Italy.
Trial summary
intraoperative hemodynamic optimization will be based on the percentage of variation of the parameters Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Hemodynamic MAP Stability
- What is being tested?
- parameters
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 104 participants
- Where
- 1 siteItaly
- Study dates
- 1 Jun 2025to 1 Jun 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
None listed.
Who cannot join
- Body Mass Index > 35 kg/m2 Pregnancy Refusal to sign written informed consent Urgent and/or emergency surgery
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Italy1 site, 1 recruiting
- Recruiting
Fondazione Policlinico Universitario Agostino Gemelli
Rome, RM, 00148
Andrea Russo, +39-06-30153160, andrea.russo@policlinicogemelli.it
About this study
Official title: A NEW APPROACH IN THE MANAGEMENT OF INTRAOPERATIVE ARTERIAL HYPOTENSION BASED ON DELTA VARIATION OF HEMODYNAMIC PARAMETERS: A RANDOMISED CLINICAL TRIAL
intraoperative hemodynamic optimization will be based on the percentage of variation of the parameters
- Conditions
- Hemodynamic MAP Stability
- Being tested
- parameters
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
parametersProcedure or surgery
during surgery hemodynamic will be optimized based on percentage variation of different variables
| Study group | Role | What they receive |
|---|---|---|
| delta | Experimental | in this group the trigger for any intervention will be the delta variation of the hemodynamic parameters showed in the monitoring platform Receives: Procedure: parameters |
| standard | No intervention | in this group hemodynamics will be managed by using the hypotension prediction index |
What is being measured
The primary outcome is the main question the study is designed to answer.
time weighted average of mean arterial pressure
we will avoid hypotensive episodes by using a predictive approach and then calculate the TWA-MAP < 65 mmHg
Measured: the end of surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Apr 2025
- Study start1 Jun 2025
- Primary completion1 May 2026 (estimated)
- Study completion1 Jun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hemodynamic MAP StabilityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 104 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, RUSSO ANDREA, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06932484
- Sponsor's protocol ID
- 7428
- Acronym
- DELTA
- Status last verified
- Jul 2025
- First submitted
- 10 Apr 2025
- Last updated
- 31 Jul 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 31 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A NEW APPROACH IN THE MANAGEMENT OF INTRAOPERATIVE ARTERIAL HYPOTENSION BASED ON DELTA VARIATION OF HEMODYNAMIC PARAMETERS: A RANDOMISED CLINICAL TRIAL
- ClinicalTrials.gov ID
- NCT06932484
- Acronym / sponsor ID
- DELTA / 7428
- Conditions
- Hemodynamic MAP Stability
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 104 participants (estimated)
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCSUniversity, hospital or other
- Study start
- 1 Jun 2025 (actual)
- Primary completion
- 1 May 2026 (estimated)
- Study completion
- 1 Jun 2027 (estimated)
- First posted
- 17 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
intraoperative hemodynamic optimization will be based on the percentage of variation of the parameters
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| delta | Experimental | Procedure: parametersin this group the trigger for any intervention will be the delta variation of the hemodynamic parameters showed in the monitoring platform |
| standard | No intervention | –in this group hemodynamics will be managed by using the hypotension prediction index |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (0 listed)
Key exclusion criteria (1 listed)
- Body Mass Index > 35 kg/m2 Pregnancy Refusal to sign written informed consent Urgent and/or emergency surgery
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| parametersduring surgery hemodynamic will be optimized based on percentage variation of different variables | Procedure or surgery | delta |
Primary outcome
time weighted average of mean arterial pressure
Time frame: the end of surgery
we will avoid hypotensive episodes by using a predictive approach and then calculate the TWA-MAP < 65 mmHg
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Jul 2025.
- Individual participant dataSharing planned: Undecided
Related trials for Hemodynamic MAP Stability
Enrolling by invitationObservational study
Unilateral Spinal vs General Anaesthesia in Low EF Patients: A Hemodynamic Comparison
Hemodynamic (MAP) Stability
Recruiting
Hemodynamic Optimization Using an Artificial Intelligenze System
Hemodynamic (MAP) Stability, Fluid Management
Not yet recruiting
Using Artificial Intelligence to Guide Fluid Therapy During Major Cancer Surgery: A Randomized Controlled Trial
Neoplasm, Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing parameters in people with Hemodynamic MAP Stability, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 0 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 31 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact andrea russo, physician (+39-06-30153212, andrea.russo@policlinicogemelli.it), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
time weighted average of mean arterial pressure (time frame: the end of surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jul 2025; AzTrials last refreshed its copy on 27 Oct 2026.